BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7871992)

  • 1. Idiopathic infantile hypercalcemia discovered in the newborn period.
    Shimizu H; Kodama S; Takeuchi A; Matui T; Nakao H; Sakurai T; Kobayashi T
    Acta Paediatr Jpn; 1994 Dec; 36(6):720-3. PubMed ID: 7871992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic infantile hypercalcemia: rapid response to treatment with calcitonin.
    Alon U; Berkowitz D; Berant M
    Child Nephrol Urol; 1992; 12(1):47-50. PubMed ID: 1606583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations.
    Hawkes CP; Li D; Hakonarson H; Meyers KE; Thummel KE; Levine MA
    J Clin Endocrinol Metab; 2017 May; 102(5):1440-1446. PubMed ID: 28324001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infantile hypercalcemia and hypercalciuria: new insights into a vitamin D-dependent mechanism and response to ketoconazole treatment.
    Nguyen M; Boutignon H; Mallet E; Linglart A; Guillozo H; Jehan F; Garabedian M
    J Pediatr; 2010 Aug; 157(2):296-302. PubMed ID: 20394945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild Idiopathic Infantile Hypercalcemia-Part 2: A Longitudinal Observational Study.
    Lenherr-Taube N; Furman M; Assor E; Elia Y; Collins C; Thummel K; Levine MA; Sochett E
    J Clin Endocrinol Metab; 2021 Sep; 106(10):2938-2948. PubMed ID: 34139759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild Idiopathic Infantile Hypercalcemia-Part 1: Biochemical and Genetic Findings.
    Lenherr-Taube N; Young EJ; Furman M; Elia Y; Assor E; Chitayat D; Uster T; Kirwin S; Robbins K; Vinette KMB; Daneman A; Marshall CR; Collins C; Thummel K; Sochett E; Levine MA
    J Clin Endocrinol Metab; 2021 Sep; 106(10):2915-2937. PubMed ID: 34125233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Screening Test for Idiopathic Infantile Hypercalcemia Confirms Residual Levels of Serum 24,25-(OH)
    Kaufmann M; Morse N; Molloy BJ; Cooper DP; Schlingmann KP; Molin A; Kottler ML; Gallagher JC; Armas L; Jones G
    J Bone Miner Res; 2017 Jul; 32(7):1589-1596. PubMed ID: 28304097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma 1,25-dihydroxyvitamin D concentrations in infants with hypercalcemia and an elfin facies.
    Garabédian M; Jacqz E; Guillozo H; Grimberg R; Guillot M; Gagnadoux MF; Broyer M; Lenoir G; Balsan S
    N Engl J Med; 1985 Apr; 312(15):948-52. PubMed ID: 3838365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of a recurrent 10.9 kb CYP24A1 deletion in Idiopathic Infantile Hypercalcemia.
    Molin A; Nowoczyn M; Coudray N; Ballandone C; Abéguilé G; Mittre H; Richard N; Eckart P; Castanet M; Kottler ML
    Eur J Med Genet; 2019 Nov; 62(11):103577. PubMed ID: 30423445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia.
    Schlingmann KP; Ruminska J; Kaufmann M; Dursun I; Patti M; Kranz B; Pronicka E; Ciara E; Akcay T; Bulus D; Cornelissen EA; Gawlik A; Sikora P; Patzer L; Galiano M; Boyadzhiev V; Dumic M; Vivante A; Kleta R; Dekel B; Levtchenko E; Bindels RJ; Rust S; Forster IC; Hernando N; Jones G; Wagner CA; Konrad M
    J Am Soc Nephrol; 2016 Feb; 27(2):604-14. PubMed ID: 26047794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iatrogenic vitamin D toxicity in an infant--a case report and review of literature.
    Ketha H; Wadams H; Lteif A; Singh RJ
    J Steroid Biochem Mol Biol; 2015 Apr; 148():14-8. PubMed ID: 25636720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Circulating metabolites of vitamin D in 14 children with hypercalcemia].
    Jacqz E; Garabedian M; Guillozo H; Bourdeau A; Guillot M; Gagnadoux MF; Broyer M; Lenoir G; Balsan S
    Arch Fr Pediatr; 1985 Mar; 42(3):225-30. PubMed ID: 3873927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human synthetic calcitonin therapy for hypercalcemia of immobilization.
    Kaul S; Sockalosky JJ
    J Pediatr; 1995 May; 126(5 Pt 1):825-7. PubMed ID: 7752017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 1,24(R)-dihydroxyvitamin D3-like bone-resorbing lipid in a patient with cancer-associated hypercalcemia.
    Shigeno C; Yamamoto I; Dokoh S; Hino M; Aoki J; Yamada K; Morita R; Kameyama M; Torizuka K
    J Clin Endocrinol Metab; 1985 Oct; 61(4):761-8. PubMed ID: 2993347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampin monotherapy for children with idiopathic infantile hypercalcemia.
    Lenherr-Taube N; Furman M; Assor E; Thummel K; Levine MA; Sochett E
    J Steroid Biochem Mol Biol; 2023 Jul; 231():106301. PubMed ID: 36990163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene.
    Fencl F; Bláhová K; Schlingmann KP; Konrad M; Seeman T
    Eur J Pediatr; 2013 Jan; 172(1):45-9. PubMed ID: 23001465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.
    Figueres ML; Linglart A; Bienaime F; Allain-Launay E; Roussey-Kessler G; Ryckewaert A; Kottler ML; Hourmant M
    Am J Kidney Dis; 2015 Jan; 65(1):122-6. PubMed ID: 25446019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.
    Molin A; Baudoin R; Kaufmann M; Souberbielle JC; Ryckewaert A; Vantyghem MC; Eckart P; Bacchetta J; Deschenes G; Kesler-Roussey G; Coudray N; Richard N; Wraich M; Bonafiglia Q; Tiulpakov A; Jones G; Kottler ML
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1343-52. PubMed ID: 26214117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases.
    Pronicka E; Ciara E; Halat P; Janiec A; Wójcik M; Rowińska E; Rokicki D; Płudowski P; Wojciechowska E; Wierzbicka A; Książyk JB; Jacoszek A; Konrad M; Schlingmann KP; Litwin M
    J Appl Genet; 2017 Aug; 58(3):349-353. PubMed ID: 28470390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.